Last updated: 6 March 2020 at 4:17pm EST

Jonathan N Rubin Net Worth

The estimated Net Worth of Jonathan N Rubin is at least $35.1 Millón dollars as of 3 March 2020. Jonathan Rubin owns over 5,675 units of Magellan Health Inc stock worth over $3,511,400 and over the last 16 years Jonathan sold MGLN stock worth over $31,616,600.

Jonathan Rubin MGLN stock SEC Form 4 insiders trading

Jonathan has made over 42 trades of the Magellan Health Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Jonathan exercised 5,675 units of MGLN stock worth $539,068 on 3 March 2020.

The largest trade Jonathan's ever made was selling 42,966 units of Magellan Health Inc stock on 6 December 2016 worth over $3,148,119. On average, Jonathan trades about 9,023 units every 58 days since 2008. As of 3 March 2020 Jonathan still owns at least 36,966 units of Magellan Health Inc stock.

You can see the complete history of Jonathan Rubin stock trades at the bottom of the page.

What's Jonathan Rubin's mailing address?

Jonathan's mailing address filed with the SEC is 55 NOD ROAD, , AVON, CT, 06001.

Insiders trading at Magellan Health Inc

Over the last 22 years, insiders at Magellan Health Inc have traded over $207,355,721 worth of Magellan Health Inc stock and bought 25,726 units worth $1,508,914 . The most active insiders traders include Peter A Feld, James E Murray y Mary F Sammons. On average, Magellan Health Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,340,119. The most recent stock trade was executed by James E Murray on 2 January 2022, trading 3,262 units of MGLN stock currently worth $309,857.

What does Magellan Health Inc do?

Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.

Complete history of Jonathan Rubin stock trades at Magellan Health Inc

Persona	Trans. Transacción	Precio total
Jonathan N Rubin Director Financiero	Uso de opción	$317,970 3 Mar 2020
Jonathan N Rubin Director Financiero	Uso de opción	$360,637 3 Mar 2019
Jonathan N Rubin Director Financiero	Uso de opción	$162,914 2 Nov 2018
Jonathan N Rubin Director Financiero	Venta	$2,893,070 3 Jan 2018
Jonathan N Rubin Director Financiero	Venta	$1,675,749 2 Jan 2018
Jonathan N Rubin Director Financiero	Uso de opción	$367,092 5 Mar 2017
Jonathan N Rubin Director Financiero	Venta	$3,148,119 6 Dec 2016
Jonathan N Rubin Director Financiero	Venta	$3,148,119 6 Dec 2016
Jonathan N Rubin Director Financiero	Venta	$116,880 5 Dec 2016
Jonathan N Rubin Director Financiero	Venta	$116,880 5 Dec 2016
Jonathan N Rubin Director Financiero	Venta	$84,215 1 Dec 2016
Jonathan N Rubin Director Financiero	Venta	$84,215 1 Dec 2016
Jonathan N Rubin Director Financiero	Venta	$556,336 30 Nov 2016
Jonathan N Rubin Director Financiero	Venta	$556,336 30 Nov 2016
Jonathan N Rubin Director Financiero	Venta	$523,993 29 Nov 2016
Jonathan N Rubin Director Financiero	Venta	$523,993 29 Nov 2016
Jonathan N Rubin Director Financiero	Uso de opción	$244,662 2 Nov 2016
Jonathan N Rubin Director Financiero	Venta	$23,652 23 Jun 2015
Jonathan N Rubin Director Financiero	Venta	$6,408 15 Apr 2015
Jonathan N Rubin Director Financiero	Venta	$1,416,369 16 Mar 2015
Jonathan N Rubin Director Financiero	Uso de opción	$364,081 5 Mar 2015
Jonathan N Rubin Director Financiero	Venta	$1,839,024 26 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$1,148,160 25 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$1,199,232 24 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$1,361,241 23 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$1,965,288 20 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$1,166,778 19 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$2,253,910 18 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$1,493,031 17 Jun 2014
Jonathan N Rubin Director Financiero	Venta	$810,889 16 Jun 2014
Jonathan N Rubin Director Financiero	Uso de opción	$239,507 5 Mar 2014
Jonathan N Rubin Director Financiero	Uso de opción	$111,684 3 Mar 2014
Jonathan N Rubin Director Financiero	Venta	$1,409,485 10 Jul 2013
Jonathan N Rubin Director Financiero	Venta	$1,618,864 9 Jul 2013
Jonathan N Rubin Director Financiero	Venta	$350,858 8 Jul 2013
Jonathan N Rubin Director Financiero	Venta	$34,212 1 Jul 2013
Jonathan N Rubin Director Financiero	Venta	$91,296 19 Jun 2013
Jonathan N Rubin Director Financiero	Uso de opción	$109,339 5 Mar 2013
Jonathan N Rubin Director Financiero	Uso de opción	$204,584 3 Mar 2013
Jonathan N Rubin Director Financiero	Uso de opción	$291,947 3 Mar 2012
Jonathan N Rubin Director Financiero	Uso de opción	$113,321 4 Mar 2011
Jonathan N Rubin Director Financiero	Uso de opción	$100,557 3 Mar 2011

Magellan Health Inc executives and stock owners

Magellan Health Inc executives and other stock owners filed with the SEC include:

Kenneth Fasola,
Chief Executive Officer, Director
Mostafa Kamal,
Chief Executive Officer - Magellan Rx Management
Steven Shulman,
Independent Chairman of the Board
Caskie Lewis-Clapper,
Chief Human Resource Officer
Peter Feld,
Independent Director
G. Scott MacKenzie,
Independent Director
Guy Sansone,
Independent Director
Leslie Norwalk,
Independent Director
Swati Abbott,
Independent Director
Joe Bogdan,
Senior Vice President, Corporate Finance
Mural Josephson,
Director
Christopher Chen,
Director
Tim Lacy,
Chief Growth Officer
Caroline Carney,
Chief Medical Officer
David Haddock,
General Counsel, Secretary
David Bourdon,
Chief Financial Officer
James Murray,
President, Chief Operating Officer
Jay Youell,
Sr. VP of Sales - Health Plan & Insurance Markets
John E. Littel,
Chief External Affairs Officer
Darren P. Lehrich,
Chief Investor Relations Officer
Renie Shapiro Silver,
SVP - Corp. Fin.
David Patrick Bourdon,
Chief Financial Officer
William J Mcbride,
Director
Eran Broshy,
Director
Barry M Smith,
Director
Perry G Md Fine,
Director
Kay Coles James,
Director
John O Agwunobi,
Director
Jeffrey N West,
SVP & Controller
Sanjeev K Srivastava,
CEO, Magellan Plan Services
Mary F Sammons,
Director
Jonathan N Rubin,
Chief Financial Officer
Michael Diament,
Director
Daniel N Gregoire,
General Counsel and Secretary
Russell C Petrella,
President, Behavioral Health
Mark S Demilio,
CFO
Raju L Mantena,
President, ICORE Healthcare
Robert W Field,
CEO, Magellan Pharm Solutions
Michael P Ressner,
Director
Tina Blasi,
CEO, National Imaging Assoc.
Robert M Leblanc,
Director
Management, L.P.Cohen Arthu...,
Kim Marie Mageau,
President, Magellan Pharm Sols
Alan Lotvin,
President, ICore Healthcare
Management, L.P.Health Cor ...,
Timothy P Nolan,
President, First Health Servic
Karen S Lynch,
President
Nancy L Johnson,
Director
Allen F Wise,
Director
Jeff D Emerson,
Chief Information Officer
Rene Lerer,
President and COO
Eric Reimer,
Chief Growth Officer
William D Forrest,
Director
Anthony M Kotin,
Chief Mkting & Strategy Offcr
Saul Burian,
Director
Keith Dixon,
President, Behavioral Health
Holdings Lp Onex Partners G...,
Michael Majerik,
Chief Sales&Marketing Officer
Matthew Joseph Simas,
Director
Robert M Haft,
Director
Gadget, L.P.Scepter Holding...,
Megan M Arthur,
Executive Vice President
Holdings Lponex Partners Lp...,